NINDS NeuroNEXT Network — OTA Clinical Trials
Supports exploratory neurological clinical research through collaborative exploratory transactions.
The NINDS NeuroNEXT Network funds exploratory clinical trials and biomarker studies for neurological diseases through a two-stage Other Transaction Authority (OTA) process. Stage 1, governed by OTA-24-013, is the preliminary application in which investigators describe the proposed trial or study concept; only applications that pass Stage 1 review may proceed to Stage 2 under OTA-24-014, which requ…
Exploratory clinical trials and biomarker studies for neurological diseases conducted within the NeuroNEXT clinical trials network.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline